Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Inhibitors of the Glutamate Vesicular Transporter (VGLUT)

Author(s): Charles M. Thompson, Erin Davis, Christina N. Carrigan, Holly D. Cox, Richard J. Bridges and John M. Gerdes

Volume 12, Issue 18, 2005

Page: [2041 - 2056] Pages: 16

DOI: 10.2174/0929867054637635

Price: $65

Abstract

The vesicular glutamate transporter (VGLUT) is responsible for the uptake of the excitatory amino acid, L-glutamate, into synaptic vesicles. VGLUT activity is coupled to an electrochemical gradient driven by a vacuolar ATPase and stimulated by low Cl - . VGLUT has relatively low affinity (Km = 1-3 mM) for glutamate and is pharmacologically and structurally distinct from the Na+-dependent, excitatory amino acid transporters (EAATs) found on the plasma membrane. Because glutamatergic neurotransmission begins with vesicular release, compounds that block the uptake of glutamate into the vesicle may reduce excitotoxic events. Several classes of competitive VGLUT inhibitors have emerged including amino acids and amino acid analogs, fatty acids, azo dyes, quinolines and alkaloids. The potency with which these agents inhibit VGLUT varies from millimolar (amino acids) to nanomolar (azo dyes) concentrations. These inhibitors represent highly diverse structures and have collectively begun to reveal key pharmacophore elements that may elucidate the key interactions important to binding VGLUT. Using known inhibitor structures and preliminary molecular modeling, a VGLUT pharmacophore is presented that will aid in the design of new, highly potent and selective agents.

Keywords: synaptic vesicle, glutamate, inhibitor, pharmacophore, transporter, vglut

Next »

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy